Cancer-Related Stigma in Malawi: Narratives of Cancer Survivors.
Journal
JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
22
2
2023
Statut:
ppublish
Résumé
Stigma is an impediment across the cancer care continuum, leading to delayed presentation to care, elevated morbidity and mortality, and reduced quality of life. The goal of this study was to qualitatively examine the drivers, manifestations, and impacts of cancer-related stigma among individuals who received cancer treatment in Malawi, and to identify opportunities to address stigma. Individuals who had completed treatment for lymphoma (n = 20) or breast cancer (n = 9) were recruited from observational cancer cohorts in Lilongwe, Malawi. Interviews explored the individual's cancer journey, from first symptoms through diagnosis, treatment, and recovery. Interviews were audio-recorded and translated from Chichewa to English. Data were coded for content related to stigma, and thematically analyzed to describe the drivers, manifestations, and impacts of stigma along the cancer journey. Drivers of cancer stigma included beliefs of cancer origin (cancer as infectious; cancer as a marker of HIV; cancer due to bewitchment), perceived changes in the individual with cancer (loss of social/economic role; physical changes), and expectations about the individual's future (cancer as death sentence). Cancer stigma manifested through gossip, isolation, and courtesy stigma toward family members. The impacts of cancer stigma included mental health distress, impediments to care engagement, lack of cancer disclosure, and self-isolation. Participants suggested the following programmatic needs: community education about cancer; counseling in health facilities; and peer support from cancer survivors. The results highlight multifactorial drivers, manifestations, and impacts of cancer-related stigma in Malawi, which may affect success of cancer screening and treatment programs. There is a clear need for multilevel interventions to improve community attitudes toward people with cancer, and to support individuals along the continuum of cancer care.
Identifiants
pubmed: 36795989
doi: 10.1200/GO.22.00307
pmc: PMC10166375
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2200307Subventions
Organisme : FIC NIH HHS
ID : K01 TW011470
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA121947
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA190152
Pays : United States
Organisme : FIC NIH HHS
ID : L30 TW011802
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA254564
Pays : United States
Organisme : FIC NIH HHS
ID : K01 TW011191
Pays : United States
Organisme : NCI NIH HHS
ID : L30 CA233709
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009340
Pays : United States
Références
JCO Glob Oncol. 2020 Sep;6:1419-1421
pubmed: 32970486
Psychooncology. 2009 Dec;18(12):1252-60
pubmed: 19156675
PLoS One. 2016 Mar 02;11(3):e0150445
pubmed: 26934054
J Am Coll Radiol. 2009 Jan;6(1):26-32
pubmed: 19111268
Soc Sci Med. 2012 May;74(10):1486-93
pubmed: 22459188
J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):558-64
pubmed: 27035888
J Psychosoc Oncol. 2011;29(1):19-34
pubmed: 21240723
Glob Public Health. 2011;6(7):719-31
pubmed: 20865612
Psychooncology. 2016 Oct;25(10):1206-1211
pubmed: 27421234
Oncol Nurs Forum. 2019 Jul 1;46(4):402-418
pubmed: 31225843
J Natl Cancer Inst. 2022 Sep 9;114(9):1228-1237
pubmed: 35640108
Lancet Glob Health. 2021 Jul;9(7):e1008-e1016
pubmed: 34022150
Afr Health Sci. 2013 Dec;13(4):1054-61
pubmed: 24940332
Lancet. 2016 Mar 12;387(10023):1123-1132
pubmed: 26410341
Cancer Causes Control. 2020 Apr;31(4):393-402
pubmed: 32124187
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18711
pubmed: 24242262
Oncologist. 2018 Jan;23(1):35-43
pubmed: 28798272
Int J Womens Health. 2015 Aug 27;7:791-8
pubmed: 26346001
Health Care Women Int. 2010 Sep;31(9):801-16
pubmed: 20677038
Health Commun. 2001;13(3):285-305
pubmed: 11550852
PLoS One. 2019 Oct 17;14(10):e0223537
pubmed: 31622363
Patient Relat Outcome Meas. 2014 Nov 07;5:131-44
pubmed: 25404863
Eur J Cancer Care (Engl). 2015 May;24(3):299-312
pubmed: 25512107
BMC Med. 2019 Feb 15;17(1):31
pubmed: 30764826
Infect Agent Cancer. 2014 May 20;9:17
pubmed: 24904686
J Psychosom Res. 2009 Nov;67(5):403-15
pubmed: 19837203
Infect Agent Cancer. 2021 Jan 7;16(1):2
pubmed: 33413521
Int J Med Sci. 2012;9(2):163-73
pubmed: 22275855
BMJ Open. 2014 Apr 11;4(4):e004783
pubmed: 24727360
Complement Ther Med. 2021 Mar;57:102661
pubmed: 33418067
J Oncol Pract. 2019 Nov;15(11):585-590
pubmed: 31509483
Breast. 2013 Apr;22(2):138-141
pubmed: 23313061
Lancet. 2021 Jun 5;397(10290):2142-2143
pubmed: 34087110